Liposome Drug Delivery Market Size to Surpass USD 13.12 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Liposome Drug Delivery Market

5.1. COVID-19 Landscape: Liposome Drug Delivery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Liposome Drug Delivery Market, By Liposome Structure

8.1. Liposome Drug Delivery Market Revenue and Volume, by January

8.1.1. Unilamellar Liposome

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Small

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Large

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Multilamellar Liposome

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Liposome Drug Delivery Market, By Product

9.1. Liposome Drug Delivery Market Revenue and Volume, by Product

9.1.1. Liposomal Doxorubicin

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Liposomal Paclitaxel

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Liposomal Amphotericin B

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Liposome Drug Delivery Market, By Technology

10.1. Liposome Drug Delivery Market Revenue and Volume, by Technology

10.1.1. Stealth Liposome Technology

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Non-PEGylated Liposome Technology

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. DepoFoam Liposome Technology

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Liposome Drug Delivery Market, By Application

11.1. Liposome Drug Delivery Market Revenue and Volume, by Application

11.1.1. Fungal Disease

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Pain Management

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Cancer Therapy

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Viral Vaccine

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Photodynamic Therapy

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Liposome Drug Delivery Market, By End-User

12.1. Liposome Drug Delivery Market Revenue and Volume, by End-User

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Specialty Centers

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Ambulatory Surgical Centers

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Liposome Drug Delivery Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by January

13.1.2. Market Revenue and Volume Forecast, by Product

13.1.3. Market Revenue and Volume Forecast, by Technology

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by January

13.1.6.2. Market Revenue and Volume Forecast, by Product

13.1.6.3. Market Revenue and Volume Forecast, by Technology

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End-User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by January

13.1.7.2. Market Revenue and Volume Forecast, by Product

13.1.7.3. Market Revenue and Volume Forecast, by Technology

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by January

13.2.2. Market Revenue and Volume Forecast, by Product

13.2.3. Market Revenue and Volume Forecast, by Technology

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by End-User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by January

13.2.6.2. Market Revenue and Volume Forecast, by Product

13.2.6.3. Market Revenue and Volume Forecast, by Technology

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by End-User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by January

13.2.9.2. Market Revenue and Volume Forecast, by Product

13.2.9.3. Market Revenue and Volume Forecast, by Technology

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by January

13.2.12.2. Market Revenue and Volume Forecast, by Product

13.2.12.3. Market Revenue and Volume Forecast, by Technology

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by January

13.2.14.2. Market Revenue and Volume Forecast, by Product

13.2.14.3. Market Revenue and Volume Forecast, by Technology

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by January

13.3.2. Market Revenue and Volume Forecast, by Product

13.3.3. Market Revenue and Volume Forecast, by Technology

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by January

13.3.6.2. Market Revenue and Volume Forecast, by Product

13.3.6.3. Market Revenue and Volume Forecast, by Technology

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by January

13.3.8.2. Market Revenue and Volume Forecast, by Product

13.3.8.3. Market Revenue and Volume Forecast, by Technology

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by January

13.3.10.2. Market Revenue and Volume Forecast, by Product

13.3.10.3. Market Revenue and Volume Forecast, by Technology

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by January

13.3.11.2. Market Revenue and Volume Forecast, by Product

13.3.11.3. Market Revenue and Volume Forecast, by Technology

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by January

13.4.2. Market Revenue and Volume Forecast, by Product

13.4.3. Market Revenue and Volume Forecast, by Technology

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by January

13.4.6.2. Market Revenue and Volume Forecast, by Product

13.4.6.3. Market Revenue and Volume Forecast, by Technology

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by January

13.4.8.2. Market Revenue and Volume Forecast, by Product

13.4.8.3. Market Revenue and Volume Forecast, by Technology

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by January

13.4.10.2. Market Revenue and Volume Forecast, by Product

13.4.10.3. Market Revenue and Volume Forecast, by Technology

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by January

13.4.11.2. Market Revenue and Volume Forecast, by Product

13.4.11.3. Market Revenue and Volume Forecast, by Technology

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by January

13.5.2. Market Revenue and Volume Forecast, by Product

13.5.3. Market Revenue and Volume Forecast, by Technology

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by January

13.5.6.2. Market Revenue and Volume Forecast, by Product

13.5.6.3. Market Revenue and Volume Forecast, by Technology

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by January

13.5.8.2. Market Revenue and Volume Forecast, by Product

13.5.8.3. Market Revenue and Volume Forecast, by Technology

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End-User

Chapter 14. Company Profiles

14.1. Johnson & Johnson Services, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Gilead Sciences, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Sun Pharmaceutical Industries Ltd.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Novartis AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Teva Pharmaceutical Industries Ltd

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Janssen Pharmaceuticals, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. CELSION Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Abbott

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Ipsen Pharma

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Spectrum Pharmaceuticals, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global liposome drug delivery market size is expected to increase USD 13.12 billion by 2034 from USD 5.59 billion in 2024.

The liposome drug delivery market is anticipated to grow at a CAGR of over 8.91% between 2025 and 2034.

The major players operating in the liposome drug delivery market are Johnson & Johnson Services, Inc., Gilead Sciences, Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd, Janssen Pharmaceuticals, Inc., CELSION Corporation, Abbott, Ipsen Pharma, Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited., and Others.

The driving factors of the liposome drug delivery market are the rising adoption of liposome drugs for skin and rise in the healthcare and pharmaceutical industr.

North America region will lead the global liposome drug delivery market during the forecast period 2025 to 2034.